Theriva Biologics, Inc. (TOVX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.08 | +89.1% |
| 2024 | $-19.03 | +33.2% |
| 2023 | $-28.48 | -2074.0% |
| 2022 | $-1.31 | +31.1% |
| 2021 | $-1.90 | -187.9% |
| 2020 | $-0.66 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.08 | +89.1% |
| 2024 | $-19.03 | +33.2% |
| 2023 | $-28.48 | -2074.0% |
| 2022 | $-1.31 | +31.1% |
| 2021 | $-1.90 | -187.9% |
| 2020 | $-0.66 | — |